Literature DB >> 35245512

An optimized procedure to record visual evoked potential in mice.

Shuting Liu1, Kangjian Xiang1, Qiannan Lei1, Suo Qiu1, Mengqing Xiang2, Kangxin Jin3.   

Abstract

Visual evoked potential (VEP) is commonly used to evaluate visual acuity in both clinical and basic studies. Subdermal needle electrodes or skull pre-implanted screw electrodes are usually used to record VEP in rodents. However, the VEP amplitudes recorded by the former are small while the latter may damage the brain. In this study, we established a new invasive procedure for VEP recording, and made a series of comparisons of VEP parameters recorded from different electrode locations, different times of day (day and night) and bilateral eyes, to evaluate the influence of these factors on VEP in mice. Our data reveal that our invasive method is reliable and can record VEP with good waveforms and large amplitudes. The comparison data show that VEP is greatly influenced by active electrode locations and difference between day and night. In C57 or CD1 ONC (optic nerve crush) models and Brn3bAP/AP mice, which are featured by loss of retinal ganglion cells (RGCs), amplitudes of VEP N1 and P1 waves are drastically reduced. The newly established VEP procedure is very reliable and stable, and is particularly useful for detecting losses of RGC quantities, functions or connections to the brain. Our analyses of various recording conditions also provide useful references for future studies.
Copyright © 2022 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Optic nerve crush (ONC); Pou4f2; Visual evoked potential (VEP)

Mesh:

Year:  2022        PMID: 35245512     DOI: 10.1016/j.exer.2022.109011

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  1 in total

1.  Low frequency visual stimulation enhances slow wave activity without disrupting the sleep pattern in mice.

Authors:  Stephen Thankachan; Chun Yang; Ksenia V Kastanenka; Brian J Bacskai; Dmitry Gerashchenko
Journal:  Sci Rep       Date:  2022-07-19       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.